The Ministry Of Health, By Force Of Court Order, Summons Companies Interested In Supplying, Via Direct Contracting, The Following Strategic Health Input: Selumetinib Concentration: 10 Mg; Regorafenib Concentration: 40 Mg; Bendamustine Concentration: 100 Mg Pharmaceutical Form: Lyophilized Powder For Injection; Teriparatide Concentration: 250 Mcg/Ml Pharmaceutical Form: Injectable Solution Additional Characteristics: With Delivery System; Ribociclib Composition: Succinate Concentration: 200 Mg; Dupilumab Concentration: 175 Mg/Ml Pharmaceutical Form: Injectable Solution Additional: Prefilled Syringe; Dupilumab Concentration: 150 Mg/Ml Pharmaceutical Form: Injectable Solution Additional: Prefilled Syringe; Canakinumab Concentration: 150 Mg Pharmaceutical Form: Lyophilized Powder For Injection; Nintedanib Composition: Esylate Salt Concentration: 150 Mg And Medicinal Extract Active Ingredient: Cannabidiol Oil Concentration: 60 Mg/Ml Pharmaceutical Form: Oral Solution - Drops Ecs Care 6000Mg - Central Pharma Care.
Avis d'appel d'offres
Nous nous efforçons de fournir des informations les plus exactes et mises à jour mais nous ne pouvons pas garantir que toutes les informations fournies sur notre site ne contiennent pas d'erreur.
Si vous avez des suggestions/corrections pour cet avis, n'hésitez pas à nous en informer.